Characteristics of a COVID-19 Cohort With Large Vessel Occlusion: A Multicenter International Study
Pascal Jabbour,Adam A Dmytriw,Ahmad Sweid,Michel Piotin,Kimon Bekelis,Nader Sourour,Eytan Raz,Italo Linfante,Guilherme Dabus,Max Kole,Mario Martínez-Galdámez,Shahid M Nimjee,Demetrius K Lopes,Ameer E Hassan,Peter Kan,Mohammad Ghorbani,Michael R Levitt,Simon Escalard,Symeon Missios,Maksim Shapiro,Frédéric Clarençon,Mahmoud Elhorany,Daniel Vela-Duarte,Rizwan A Tahir,Patrick P Youssef,Aditya S Pandey,Robert M Starke,Kareem El Naamani,Rawad Abbas,Bassel Hammoud,Ossama Y Mansour,Jorge Galvan,Joshua T Billingsley,Abolghasem Mortazavi,Melanie Walker,Mahmoud Dibas,Fabio Settecase,Manraj K S Heran,Anna L Kuhn,Ajit S Puri,Bijoy K Menon,Sanjeev Sivakumar,Ashkan Mowla,Salvatore D'Amato,Alicia M Zha,Daniel Cooke,Mayank Goyal,Hannah Wu,Jake Cohen,David Turkel-Parrella,Andrew Xavier,Muhammad Waqas,Vincent M Tutino,Adnan Siddiqui,Gaurav Gupta,Anil Nanda,Priyank Khandelwal,Cristina Tiu,Pere C Portela,Natalia Perez de la Ossa,Xabier Urra,Mercedes de Lera,Juan F Arenillas,Marc Ribo,Manuel Requena,Mariangela Piano,Guglielmo Pero,Keith De Sousa,Fawaz Al-Mufti,Zafar Hashim,Sanjeev Nayak,Leonardo Renieri,Mohamed A Aziz-Sultan,Thanh N Nguyen,Patricia Feineigle,Aman B Patel,James E Siegler,Khodr Badih,Jonathan A Grossberg,Hassan Saad,M Reid Gooch,Nabeel A Herial,Robert H Rosenwasser,Stavropoula Tjoumakaris,Ambooj Tiwari
DOI: https://doi.org/10.1227/neu.0000000000001902
IF: 5.315
2022-06-01
Neurosurgery
Abstract:Background: The mechanisms and outcomes in coronavirus disease (COVID-19)-associated stroke are unique from those of non-COVID-19 stroke. Objective: To describe the efficacy and outcomes of acute revascularization of large vessel occlusion (LVO) in the setting of COVID-19 in an international cohort. Methods: We conducted an international multicenter retrospective study of consecutively admitted patients with COVID-19 with concomitant acute LVO across 50 comprehensive stroke centers. Our control group constituted historical controls of patients presenting with LVO and receiving a mechanical thrombectomy between January 2018 and December 2020. Results: The total cohort was 575 patients with acute LVO; 194 patients had COVID-19 while 381 patients did not. Patients in the COVID-19 group were younger (62.5 vs 71.2; P < .001) and lacked vascular risk factors (49, 25.3% vs 54, 14.2%; P = .001). Modified thrombolysis in cerebral infarction 3 revascularization was less common in the COVID-19 group (74, 39.2% vs 252, 67.2%; P < .001). Poor functional outcome at discharge (defined as modified Ranklin Scale 3-6) was more common in the COVID-19 group (150, 79.8% vs 132, 66.7%; P = .004). COVID-19 was independently associated with a lower likelihood of achieving modified thrombolysis in cerebral infarction 3 (odds ratio [OR]: 0.4, 95% CI: 0.2-0.7; P < .001) and unfavorable outcomes (OR: 2.5, 95% CI: 1.4-4.5; P = .002). Conclusion: COVID-19 was an independent predictor of incomplete revascularization and poor outcomes in patients with stroke due to LVO. Patients with COVID-19 with LVO were younger, had fewer cerebrovascular risk factors, and suffered from higher morbidity/mortality rates.